American Tower is a holding company. Through its subsidiaries, the company is a real estate investment trusts and an independent owner, operator and developer of multitenant communications real estate. The company's primary business is the leasing of space on communications sites to wireless service providers, radio and television broadcast companies, wireless data providers, government agencies and municipalities and tenants in a number of other industries. The company also provides tower-related services, including site acquisition, zoning and permitting and structural analysis, which primarily support the company's site leasing business, including the addition of new tenants and equipment on its sites.

Axogen provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include: Avance Nerve Graft, which is an off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard Nerve Connector, which is a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; Axoguard Nerve Protector, which is a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.

Deckers Outdoor is engaged in designing, marketing and distributing footwear, apparel and accessories. The company markets its products primarily under five brands. The UGG brand is comprised of a line of footwear, apparel and accessories for women, men and children. The HOKA brand is a line of footwear and apparel. The Teva brand's product line includes sandals, shoes, and boots. Sanuk brand is comprised of casual shoe and sandal categories. Other brands consist of Koolaburra by UGG brand, a casual footwear fashion using sheepskin and other plush materials. The company's retail stores are primarily UGG brand concept and UGG brand outlet stores.

Flowers Foods produces a range of breads, buns, rolls, snack cakes, and tortillas and is a producer and marketer of packaged bakery foods in the United States. The company also sells returned and surplus product through a system of thrift stores. The company supplies national and regional restaurants, institutions and foodservice distributors, and retail in-store bakeries with breads and rolls; sells packaged bakery products to wholesale distributors for sale to a variety of food outlets; and sells packaged snack cakes primarily to customers who distribute them nationwide through various channels of distribution, including merchandisers, supermarkets, vending outlets and convenience stores.

Lumber Liquidators Holdings is a holding company. Through its subsidiaries, the company engages in business as a multi-channel retailer of hard-surface flooring, and hard-surface flooring improvements and accessories, operating as a single operating segment. The company provides exotic and domestic hardwood species, engineered hardwood, laminate, resilient vinyl, waterproof vinyl plank and porcelain tile flooring direct to the consumer. The company features the renewable flooring products, bamboo and cork, and provides a selection of flooring improvements and accessories, including moldings, noise-reducing underlayment, adhesives and flooring tools. The company also provides in-home delivery and installation services.

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's pipeline consists of two clinical-stage product candidates, maralixibat and volixibat, with mechanisms of action that have potential utility across a wide range of orphan liver diseases.

SIGA Technologies is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks, vaccines and therapies for emerging infectious diseases, and health preparedness. The company's primary product is an oral formulation of TPOXX?, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The United States Food and Drug Administration has approved oral TPOXX? for the treatment of smallpox.

Turning Point Therapeutics is a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies. The company develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer in TKI-na?ve and TKI-pretreated patients. The company's main drug candidate is repotrectinib (TPX-0005). In addition to repotrectinib, the company's pipeline includes two clinical-stage multi-targeted kinase inhibitors, TPX-0022 (a MET/CSF1R/SRC inhibitor) and TPX-0046 (a RET/SRC inhibitor), and a preclinical ALK inhibitor, TPX-0131, which is entering IND-enabling studies. The company's fourth drug candidate, TPX-0131 is a preclinical ALK inhibitor.

Wayside Technology Group is an information technology channel company. The company provides a line of products from software vendors and tools for virtualization/cloud computing, security, networking, storage and infrastructure management, application lifecycle management and other domains as well as computer hardware. The company's Lifeboat Distribution segment distributes technical software to corporate resellers, value added resellers, consultants and systems integrators. The company's TechXtend segment is a reseller of software, hardware and services, selling to end user corporations, government organizations and academic institutions.